ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 716679 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 716679; 2) Community: the network communities that were significantly associated with the response to NSC 716679; 3) Molecule: the relationships between components within communities and NSC 716679; 4) MDR: the compounds that were significantly associated with the NSC 716679.

NSC Compound Enrichment Correlation
NSC 697932 Null 0.000864859564133839 0.35085161
NSC 749193 Null 0.000930692338491037 0.317337
NSC 750746 (E)-1-(3,4-dimethoxyphenyl)-3-(2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl)prop-2-en-1-one 0.00115358042961468 0.43962551
NSC 113951 6-Bromotoyocamycin 0.00115358042961469 0.47612529
NSC 39202 Cyclohexanone, 2,6-bis(piperidinomethyl)- 0.00115358042961469 0.40583501
NSC 618757 (E,E)-Piperidinium, 3,5-bis{[4-(dimethylamino)phenyl]methylene}-1,1-dimethyl-4-oxo, iodide 0.00115358042961469 0.39443977
NSC 626163 Discorhabdin C-nitrodienone . TFA 0.00115358042961469 0.3870254
NSC 682824 Propanimidoyl chloride, N-[[[(3-chloro-4-fluorophenyl) amino]carbonyl]oxy]-2-methyl- 0.00115358042961469 0.48342312
NSC 683834 Null 0.00115358042961469 0.49833501
NSC 685833 7H-Purine, 2,6-dichloro- 7-[2-deoxy-3,5-O-bis(4-methylphenyl)- .beta.-D-ribofuranosyl]- 0.00115358042961469 0.48886392
Total:116  Current:8    [First] [Prev] [Next] [Last]